{"transactions":[{"id":2605421,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-08-12T16:03:18.000Z","date":"2021-08-10","kind":"tax_withholding","acquired":false,"shares":1386,"price":19.03,"value":26375.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":143694,"source":{"system":"sec-edgar","filing":"0001192482-21-000662","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000662/edgar.xml","form_type":"4"}},{"id":2757864,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-04-05T18:54:14.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":7900,"price":23.38,"value":184702.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":145080,"source":{"system":"sec-edgar","filing":"0001192482-21-000309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000309/edgar.xml","form_type":"4"}},{"id":2757863,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-04-05T18:54:14.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":1757,"price":23.38,"value":41078.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":152980,"source":{"system":"sec-edgar","filing":"0001192482-21-000309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000309/edgar.xml","form_type":"4"}},{"id":2764229,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-04-01T16:14:52.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":5984,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 5,984 performance share units granted on February 5, 2020."}],"balance_after":154737,"source":{"system":"sec-edgar","filing":"0001192482-21-000288","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000288/edgar.xml","form_type":"4"}},{"id":2813552,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"exercise","acquired":false,"shares":1449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was fully vested and exercisable as of January 19, 2018."}],"balance_after":0,"derivative":{"exercise_price":3.31,"expiration_date":"2021-02-08","underlying":"Common Stock","underlying_shares":1449},"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813551,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"exercise","acquired":false,"shares":1811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was fully vested and exercisable as of January 19, 2018."}],"balance_after":0,"derivative":{"exercise_price":0.9,"expiration_date":"2020-02-26","underlying":"Common Stock","underlying_shares":1811},"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813550,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"exercise","acquired":false,"shares":64,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was fully vested and exercisable as of January 19, 2018."}],"balance_after":0,"derivative":{"exercise_price":0.9,"expiration_date":"2019-04-23","underlying":"Common Stock","underlying_shares":64},"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813549,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-12","kind":"exercise","acquired":false,"shares":5753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was fully vested and exercisable as of January 12, 2018."}],"balance_after":0,"derivative":{"exercise_price":0.48,"expiration_date":"2023-01-24","underlying":"Common Stock","underlying_shares":5753},"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813548,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-12","kind":"exercise","acquired":false,"shares":1747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was fully vested and exercisable as of January 12, 2018."}],"balance_after":64,"derivative":{"exercise_price":0.9,"expiration_date":"2019-04-23","underlying":"Common Stock","underlying_shares":1747},"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813547,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":6011,"price":23.36,"value":140416.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2020."}],"balance_after":148753,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813546,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-05-10","kind":"sale","acquired":false,"shares":1400,"price":27,"value":37800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018."}],"balance_after":154764,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813545,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"sale","acquired":false,"shares":1449,"price":23,"value":33327.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":156164,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813544,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"exercise","acquired":true,"shares":1449,"price":3.31,"value":4796.19,"ownership":{"direct":true},"balance_after":157613,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813543,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"sale","acquired":false,"shares":1811,"price":23,"value":41653.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":156164,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813542,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"exercise","acquired":true,"shares":1811,"price":0.9,"value":1629.9,"ownership":{"direct":true},"balance_after":157975,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813541,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"sale","acquired":false,"shares":64,"price":23,"value":1472.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":156164,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813540,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-19","kind":"exercise","acquired":true,"shares":64,"price":0.9,"value":57.6,"ownership":{"direct":true},"balance_after":156228,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813539,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-12","kind":"sale","acquired":false,"shares":5753,"price":21,"value":120813.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":156164,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813538,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-12","kind":"exercise","acquired":true,"shares":5753,"price":0.48,"value":2761.44,"ownership":{"direct":true},"balance_after":161917,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813537,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-12","kind":"sale","acquired":false,"shares":1747,"price":21,"value":36687.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":156164,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2813536,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-03-03T20:01:50.000Z","date":"2018-01-12","kind":"exercise","acquired":true,"shares":1747,"price":0.9,"value":1572.3,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Certain transactions reported in this Form 4 are late due to an administrative error."}],"balance_after":157911,"source":{"system":"sec-edgar","filing":"0001192482-21-000211","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000211/edgar.xml","form_type":"4"}},{"id":2863335,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-02-12T16:15:49.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":5045,"price":25.95,"value":130917.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":156164,"source":{"system":"sec-edgar","filing":"0001192482-21-000149","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000149/edgar.xml","form_type":"4"}},{"id":2863334,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2021-02-12T16:15:49.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":2099,"price":25.95,"value":54469.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":161209,"source":{"system":"sec-edgar","filing":"0001192482-21-000149","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000149/edgar.xml","form_type":"4"}},{"id":2899297,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-22T16:12:29.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":6529,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,529 performance share units granted in two prior years."}],"balance_after":163308,"source":{"system":"sec-edgar","filing":"0001192482-21-000101","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000101/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2899296,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-22T16:12:29.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":45360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":156779,"source":{"system":"sec-edgar","filing":"0001192482-21-000101","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000101/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2900721,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-21T16:30:25.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":129600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":129600,"derivative":{"exercise_price":24.06,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":129600},"source":{"system":"sec-edgar","filing":"0001192482-21-000086","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000086/edgar.xml","form_type":"4"}},{"id":2900720,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-21T16:30:25.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":6529,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 6,529 performance share units granted in two prior years."}],"balance_after":163308,"source":{"system":"sec-edgar","filing":"0001192482-21-000086","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000086/edgar.xml","form_type":"4"}},{"id":2900719,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-21T16:30:25.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":45360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":156779,"source":{"system":"sec-edgar","filing":"0001192482-21-000086","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000086/edgar.xml","form_type":"4"}},{"id":2911004,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-11T17:06:11.000Z","date":"2021-01-07","kind":"exercise","acquired":false,"shares":16042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was fully vested and exercisable as of January 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":5.73,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":16042},"source":{"system":"sec-edgar","filing":"0001192482-21-000050","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000050/edgar.xml","form_type":"4"}},{"id":2911003,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-11T17:06:11.000Z","date":"2018-01-19","kind":"exercise","acquired":false,"shares":3336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the time of exercise, 3,336 shares under the option were exercisable. The option, initially representing a right to purchase a total of 60,378 shares, vested and became exercisable over a four-year period commencing on March 19, 2015. The option vested and became exercisable in equal installments (rounded up to the nearest whole share) on a monthly basis over a four-year period commencing on March 19, 2015, subject to the employee's continued service with the issuer."}],"balance_after":16042,"derivative":{"exercise_price":5.73,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":3336},"source":{"system":"sec-edgar","filing":"0001192482-21-000050","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000050/edgar.xml","form_type":"4"}},{"id":2911002,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-11T17:06:11.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":16042,"price":22,"value":352924.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales occurring on January 7, 2021 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."}],"balance_after":111419,"source":{"system":"sec-edgar","filing":"0001192482-21-000050","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000050/edgar.xml","form_type":"4"}},{"id":2911001,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-11T17:06:11.000Z","date":"2021-01-07","kind":"exercise","acquired":true,"shares":16042,"price":5.73,"value":91920.66,"ownership":{"direct":true},"balance_after":127461,"source":{"system":"sec-edgar","filing":"0001192482-21-000050","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000050/edgar.xml","form_type":"4"}},{"id":2911000,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-11T17:06:11.000Z","date":"2018-01-19","kind":"sale","acquired":false,"shares":3336,"price":23,"value":76728.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales occurring on January 19, 2018 reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":111419,"source":{"system":"sec-edgar","filing":"0001192482-21-000050","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000050/edgar.xml","form_type":"4"}},{"id":2910999,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-11T17:06:11.000Z","date":"2018-01-19","kind":"exercise","acquired":true,"shares":3336,"price":5.73,"value":19115.28,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The transactions reported in this Form 4 occurring on January 19, 2018 are late due to an administrative error."}],"balance_after":114755,"source":{"system":"sec-edgar","filing":"0001192482-21-000050","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248221000050/edgar.xml","form_type":"4"}},{"id":2955186,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-12-07T16:03:05.000Z","date":"2020-12-03","kind":"sale","acquired":false,"shares":5967,"price":19.24,"value":114805.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.03 to $19.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":111419,"source":{"system":"sec-edgar","filing":"0001192482-20-000799","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000799/edgar.xml","form_type":"4"}},{"id":2971329,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-11-20T16:28:00.000Z","date":"2020-11-18","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully vested and exercisable as of November 18, 2020."}],"balance_after":19378,"derivative":{"exercise_price":5.73,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001192482-20-000793","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000793/edgar.xml","form_type":"4"}},{"id":2971328,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-11-20T16:28:00.000Z","date":"2020-11-18","kind":"exercise","acquired":true,"shares":16000,"price":5.73,"value":91680.0,"ownership":{"direct":true},"balance_after":117386,"source":{"system":"sec-edgar","filing":"0001192482-20-000793","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000793/edgar.xml","form_type":"4"}},{"id":3060301,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-08-12T16:04:32.000Z","date":"2020-08-10","kind":"tax_withholding","acquired":false,"shares":1515,"price":18.89,"value":28618.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":101386,"source":{"system":"sec-edgar","filing":"0001192482-20-000665","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000665/edgar.xml","form_type":"4"}},{"id":3147284,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-05-15T16:16:13.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":2728,"price":22.74,"value":62034.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.19 to $22.98, inclusive."}],"balance_after":102901,"source":{"system":"sec-edgar","filing":"0001192482-20-000347","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000347/edgar.xml","form_type":"4"}},{"id":3147283,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-05-15T16:16:13.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":5261,"price":21.12,"value":111112.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.89 to $21.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":105629,"source":{"system":"sec-edgar","filing":"0001192482-20-000347","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000347/edgar.xml","form_type":"4"}},{"id":3277078,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-02-12T16:28:46.000Z","date":"2020-02-10","kind":"tax_withholding","acquired":false,"shares":3568,"price":21.62,"value":77140.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":110890,"source":{"system":"sec-edgar","filing":"0001192482-20-000151","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000151/edgar.xml","form_type":"4"}},{"id":3284529,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-07T16:41:54.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":25000,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001192482-20-000140","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000140/edgar.xml","form_type":"4"}},{"id":3284528,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-02-07T16:41:54.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":18616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on April 1, 2021, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on the vesting date in shares of the issuer's common stock."}],"balance_after":114458,"source":{"system":"sec-edgar","filing":"0001192482-20-000140","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000140/edgar.xml","form_type":"4"}},{"id":3284527,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-02-07T16:41:54.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":95842,"source":{"system":"sec-edgar","filing":"0001192482-20-000140","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000140/edgar.xml","form_type":"4"}},{"id":3305309,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2020-01-22T16:27:48.000Z","date":"2020-01-21","kind":"tax_withholding","acquired":false,"shares":214,"price":21.56,"value":4613.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":73342,"source":{"system":"sec-edgar","filing":"0001192482-20-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248220000044/edgar.xml","form_type":"4"}},{"id":3372940,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-11-13T16:32:40.000Z","date":"2019-11-08","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully vested and exercisable as of November 8, 2019."}],"balance_after":35378,"derivative":{"exercise_price":5.73,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001192482-19-000405","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000405/edgar.xml","form_type":"4"}},{"id":3372939,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-11-13T16:32:40.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":25000,"price":19.44,"value":486000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.71, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":73556,"source":{"system":"sec-edgar","filing":"0001192482-19-000405","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000405/edgar.xml","form_type":"4"}},{"id":3372938,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-11-13T16:32:40.000Z","date":"2019-11-08","kind":"exercise","acquired":true,"shares":25000,"price":5.73,"value":143250.0,"ownership":{"direct":true},"balance_after":98556,"source":{"system":"sec-edgar","filing":"0001192482-19-000405","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000405/edgar.xml","form_type":"4"}},{"id":3439960,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-08-13T16:47:56.000Z","date":"2019-08-09","kind":"tax_withholding","acquired":false,"shares":1517,"price":11.24,"value":17051.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":73556,"source":{"system":"sec-edgar","filing":"0001192482-19-000341","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000341/edgar.xml","form_type":"4"}},{"id":3457401,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-07-23T16:04:38.000Z","date":"2019-07-19","kind":"tax_withholding","acquired":false,"shares":181,"price":10.35,"value":1873.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":75073,"source":{"system":"sec-edgar","filing":"0001192482-19-000322","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000322/edgar.xml","form_type":"4"}},{"id":3665953,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-02-11T17:03:45.000Z","date":"2019-02-08","kind":"tax_withholding","acquired":false,"shares":2714,"price":14.39,"value":39054.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":75254,"source":{"system":"sec-edgar","filing":"0001192482-19-000075","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000075/edgar.xml","form_type":"4"}},{"id":3683856,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-01-29T16:42:18.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":25600,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":25600},"source":{"system":"sec-edgar","filing":"0001192482-19-000059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000059/edgar.xml","form_type":"4"}},{"id":3683855,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-01-29T16:42:18.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":77968,"source":{"system":"sec-edgar","filing":"0001192482-19-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000059/edgar.xml","form_type":"4"}},{"id":3689445,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2019-01-23T16:17:03.000Z","date":"2019-01-18","kind":"tax_withholding","acquired":false,"shares":214,"price":15.76,"value":3372.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":52368,"source":{"system":"sec-edgar","filing":"0001192482-19-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248219000041/edgar.xml","form_type":"4"}},{"id":3832816,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-27T16:04:47.000Z","date":"2018-08-23","kind":"tax_withholding","acquired":false,"shares":599,"price":18.03,"value":10799.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":52582,"source":{"system":"sec-edgar","filing":"0001192482-18-000413","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000413/edgar.xml","form_type":"4"}},{"id":3851926,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-08-06T17:39:36.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":181,"price":20.15,"value":3647.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":53181,"source":{"system":"sec-edgar","filing":"0001192482-18-000376","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000376/edgar.xml","form_type":"4"}},{"id":3895528,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-06-13T16:58:46.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":4096,"price":27,"value":110592.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":53362,"source":{"system":"sec-edgar","filing":"0001192482-18-000292","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000292/edgar.xml","form_type":"4"}},{"id":3969886,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to purchase)","published_at":"2018-04-04T16:50:30.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":3917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"3,917 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vested and became exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vested in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":0,"derivative":{"exercise_price":0.28,"expiration_date":"2024-03-05","underlying":"Common Stock","underlying_shares":3917},"source":{"system":"sec-edgar","filing":"0001192482-18-000151","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000151/edgar.xml","form_type":"4"}},{"id":3969885,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to purchase)","published_at":"2018-04-04T16:50:30.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":4225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"4,225 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vested and became exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer."}],"balance_after":0,"derivative":{"exercise_price":0.28,"expiration_date":"2024-03-05","underlying":"Common Stock","underlying_shares":4225},"source":{"system":"sec-edgar","filing":"0001192482-18-000151","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000151/edgar.xml","form_type":"4"}},{"id":3969884,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-04-04T16:50:30.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":3917,"price":0.28,"value":1096.76,"ownership":{"direct":true},"balance_after":57458,"source":{"system":"sec-edgar","filing":"0001192482-18-000151","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000151/edgar.xml","form_type":"4"}},{"id":3969883,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-04-04T16:50:30.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":4225,"price":0.28,"value":1183.0,"ownership":{"direct":true},"balance_after":53541,"source":{"system":"sec-edgar","filing":"0001192482-18-000151","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000151/edgar.xml","form_type":"4"}},{"id":4023946,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-03-01T16:03:30.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":1193,"price":21.77,"value":25971.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":49316,"source":{"system":"sec-edgar","filing":"0001192482-18-000097","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000097/edgar.xml","form_type":"4"}},{"id":4073801,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-02-06T16:16:07.000Z","date":"2018-02-05","kind":"tax_withholding","acquired":false,"shares":214,"price":23.38,"value":5003.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":50509,"source":{"system":"sec-edgar","filing":"0001192482-18-000076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000076/edgar.xml","form_type":"4"}},{"id":4086589,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-01-29T19:37:01.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable over a four-year period commencing on February 10, 2018.  Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":24.35,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001192482-18-000061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000061/edgar.xml","form_type":"4"}},{"id":4086588,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-01-29T19:37:01.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018.  Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock."}],"balance_after":50723,"source":{"system":"sec-edgar","filing":"0001192482-18-000061","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000061/edgar.xml","form_type":"4"}},{"id":4100534,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to purchase)","published_at":"2018-01-12T16:15:50.000Z","date":"2018-01-10","kind":"exercise","acquired":false,"shares":6928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the options were fully vested and exercisable as of January 10, 2018."}],"balance_after":5753,"derivative":{"exercise_price":0.48,"expiration_date":"2023-01-24","underlying":"Common Stock","underlying_shares":6928},"source":{"system":"sec-edgar","filing":"0001192482-18-000037","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000037/edgar.xml","form_type":"4"}},{"id":4100533,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-01-12T16:15:50.000Z","date":"2018-01-10","kind":"sale","acquired":false,"shares":6928,"price":19.07,"value":132116.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25723,"source":{"system":"sec-edgar","filing":"0001192482-18-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000037/edgar.xml","form_type":"4"}},{"id":4100532,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2018-01-12T16:15:50.000Z","date":"2018-01-10","kind":"exercise","acquired":true,"shares":6928,"price":0.48,"value":3325.44,"ownership":{"direct":true},"balance_after":32651,"source":{"system":"sec-edgar","filing":"0001192482-18-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248218000037/edgar.xml","form_type":"4"}},{"id":4154409,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to purchase)","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-21","kind":"exercise","acquired":false,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"2,410 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vests and becomes exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":3917,"derivative":{"exercise_price":0.28,"expiration_date":"2024-03-05","underlying":"Common Stock","underlying_shares":572},"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154408,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to purchase)","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-17","kind":"exercise","acquired":false,"shares":1239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"2,410 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vests and becomes exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":4489,"derivative":{"exercise_price":0.28,"expiration_date":"2024-03-05","underlying":"Common Stock","underlying_shares":1239},"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154407,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to purchase)","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-17","kind":"exercise","acquired":false,"shares":1950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2,600 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vests and becomes exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer."}],"balance_after":4225,"derivative":{"exercise_price":0.28,"expiration_date":"2024-03-05","underlying":"Common Stock","underlying_shares":1950},"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154406,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-21","kind":"sale","acquired":false,"shares":572,"price":19,"value":10868.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":25723,"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154405,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-21","kind":"exercise","acquired":true,"shares":572,"price":0.28,"value":160.16,"ownership":{"direct":true},"balance_after":26295,"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154404,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":840,"price":17,"value":14280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":25723,"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154403,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":1239,"price":17,"value":21063.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":26563,"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154402,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-17","kind":"exercise","acquired":true,"shares":1239,"price":0.28,"value":346.92,"ownership":{"direct":true},"balance_after":27802,"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154401,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":1950,"price":17,"value":33150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":26563,"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4154400,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-11-21T17:41:29.000Z","date":"2017-11-17","kind":"exercise","acquired":true,"shares":1950,"price":0.28,"value":546.0,"ownership":{"direct":true},"balance_after":28513,"source":{"system":"sec-edgar","filing":"0001192482-17-000282","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000282/edgar.xml","form_type":"4"}},{"id":4179505,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to purchase)","published_at":"2017-10-27T16:58:38.000Z","date":"2017-10-25","kind":"exercise","acquired":false,"shares":1811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of these options were fully vested and excercisable as of October 25, 2017."}],"balance_after":0,"derivative":{"exercise_price":3.38,"expiration_date":"2017-11-01","underlying":"Common Stock","underlying_shares":1811},"source":{"system":"sec-edgar","filing":"0001192482-17-000263","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000263/edgar.xml","form_type":"4"}},{"id":4179504,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-10-27T16:58:38.000Z","date":"2017-10-25","kind":"exercise","acquired":true,"shares":1811,"price":3.38,"value":6121.18,"ownership":{"direct":true},"balance_after":26563,"source":{"system":"sec-edgar","filing":"0001192482-17-000263","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000263/edgar.xml","form_type":"4"}},{"id":4242357,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-08-04T16:14:20.000Z","date":"2017-08-04","kind":"tax_withholding","acquired":false,"shares":200,"price":12.39,"value":2478.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":24752,"source":{"system":"sec-edgar","filing":"0001192482-17-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000212/edgar.xml","form_type":"4"}},{"id":4242356,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-08-04T16:14:20.000Z","date":"2017-07-28","kind":"grant","acquired":true,"shares":639,"price":10.6,"value":6773.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":24952,"source":{"system":"sec-edgar","filing":"0001192482-17-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000212/edgar.xml","form_type":"4"}},{"id":4376500,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-03-21T16:42:16.000Z","date":"2017-03-17","kind":"tax_withholding","acquired":false,"shares":388,"price":14.95,"value":5800.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":24313,"source":{"system":"sec-edgar","filing":"0001192482-17-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000085/edgar.xml","form_type":"4"}},{"id":4449117,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2017-02-14T17:56:34.000Z","date":"2017-02-10","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable over a four-year period commencing on February 10, 2017.  Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2018, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer."}],"balance_after":32500,"derivative":{"exercise_price":15.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001192482-17-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000042/edgar.xml","form_type":"4"}},{"id":4449116,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-02-14T17:56:34.000Z","date":"2017-02-10","kind":"grant","acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2017.  Twenty-five percent (25%) of the restricted stock units vest on February 10, 2018, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock."}],"balance_after":24701,"source":{"system":"sec-edgar","filing":"0001192482-17-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000042/edgar.xml","form_type":"4"}},{"id":4449115,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":136328,"kind":"person","name":"Fleming Alison B","position":1,"cik":"0001640701","reported_name":"Fleming Alison B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2017-02-14T17:56:34.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":1240,"price":10.08,"value":12499.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":8451,"source":{"system":"sec-edgar","filing":"0001192482-17-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640701/000119248217000042/edgar.xml","form_type":"4"}}]}